| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
CompoSecure Inc (NYSE:CMPO) generated healthy margin expansion and accelerating organic growth in the third quarter, according to JPMorgan.
The CompoSecure Analyst: Analyst Reginald Smith upgraded the rating from Underweight to Neutral. He also raised the price target from $16 to $20.
The CompoSecure Thesis: The company's margin expansion and reacceleration in organic growth "appears to be sustainable," Smith said.
Check out other analyst stock ratings.
Management raised their 2025 revenue and EBITDA guidance by more than the third-quarter beat, implying high-teens year-on-year growth in the fourth quarter, the analyst stated.
CompoSecure also introduced its 2026 guidance, calling for 10% revenue growth and EBITDA margin expansion of as much as 170 basis points (bps) to 37.3%, ahead of Street estimates, he added.
Smith raised the adjusted EBITDA estimates for 2025 and 2026 from $157 million to $168 million and from $164 million to $187 million, respectively, saying that this does not include the Husky acquisition, which is expected to close in the first quarter of next year.
CMPO Price Action: Shares of CompoSecure had risen by 0.09% to $20.84 at the time of publication on Wednesday.
Read More:
Image: Shutterstock
Posted In: CMPO
